Colossal Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
193
- Latest Deal Type
-
Later Stage VC
- (Rumor/Speculation)
- Investors
-
83
Colossal General Information
Description
Developer of genetic engineering technologies designed to advance genomics and biodiversity conservation. The company offers gene-editing and CRISPR-based technologies for species restoration, endangered species conservation, and ecosystem recovery, enabling environmental organizations and research institutions to preserve biodiversity and restore ecological balance.
Contact Information
Website
www.colossal.comCorporate Office
- 1401 Lavaca Street
- Unit Number 155
- Austin, TX 78701
- United States
Corporate Office
- 1401 Lavaca Street
- Unit Number 155
- Austin, TX 78701
- United States
Colossal Timeline
Colossal Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | Rumor/Speculation | Generating Revenue | ||||
| 6. Later Stage VC (Series C) | 17-Sep-2025 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 30-Jan-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 06-Feb-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 13-Sep-2021 | $15M | $15M | Completed | Generating Revenue | |
| 1. University Spin-Out | 29-Jul-2021 | Completed | Generating Revenue |
Colossal Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A | ||||||||
| Seed-2 | 8,000,000 | $0.000001 | 6% | $1.21 | $1.21 | 1x | $1.21 | 2.25% |
| Seed-1 | 49,000,000 | $0.000001 | 6% | $0.17 | $0.17 | 1x | $0.17 | 13.78% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Colossal Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
News about Colossal
Dive into recent articles by PitchBook offering invaluable insights and context.
Colossal Patents
Colossal Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026207523-A1 | An ultrasound and needle guide apparatus for animal oocyte collection | Pending | 28-Mar-2025 | ||
| WO-2026174158-A1 | Culture medium suitable for culturing columbidae cells | Pending | 14-Feb-2025 | ||
| WO-2026174076-A2 | Compositions and methods for genetically engineering mammoth phenotypic traits | Pending | 12-Feb-2025 | ||
| WO-2026174076-A3 | Compositions and methods for genetically engineering mammoth phenotypic traits | Pending | 12-Feb-2025 | ||
| WO-2026156219-A1 | Non-hematopoietic cells from peripheral blood and uses thereof | Pending | 17-Jan-2025 | A01K67/0273 |
Colossal Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Colossal Investors (83)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Epping Forest Venture Holdings | Growth/Expansion | Minority | ||
| Evolution VC Partners | Venture Capital | Minority | ||
| Iconic Private Equity Partners | PE/Buyout | Minority | ||
| Indicator Ventures | Venture Capital | Minority | ||
| Innovent Capital Group | Venture Capital | Minority |
Colossal Acquisitions (1)
Colossal’s most recent deal was a Merger/Acquisition with ViaGen. The deal was made on 04-Nov-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ViaGen | 04-Nov-2025 | Merger/Acquisition | Animal Husbandry |
Colossal FAQs
-
When was Colossal founded?
Colossal was founded in 2021.
-
Where is Colossal headquartered?
Colossal is headquartered in Austin, TX.
-
What is the size of Colossal?
Colossal has 193 total employees.
-
What industry is Colossal in?
Colossal’s primary industry is Biotechnology.
-
Is Colossal a private or public company?
Colossal is a Private company.
-
What is the current valuation of Colossal?
The current valuation of Colossal is .
-
What is Colossal’s current revenue?
The current revenue for Colossal is .
-
How much funding has Colossal raised over time?
Colossal has raised $853M.
-
Who are Colossal’s investors?
Epping Forest Venture Holdings, Evolution VC Partners, Iconic Private Equity Partners, Indicator Ventures, and Innovent Capital Group are 5 of 83 investors who have invested in Colossal.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
